Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Roche extends hostile bid for Illumina
Roche extends hostile bid for Illumina
Marketwatch
Roche
hostile bid
M&A
Illumina
What Recalls? J&J CEO Gets A 55% Bonus Increase
What Recalls? J&J CEO Gets A 55% Bonus Increase
Pharmalot
William Weldon
executive pay
recalls
JNJ
Questcor Pharmaceuticals Beats Up on Analysts Yet Again
Questcor Pharmaceuticals Beats Up on Analysts Yet Again
Motley Fool
Questcor
earnings
ISTA Pharmaceuticals Misses on Revenues but Beats on EPS
ISTA Pharmaceuticals Misses on Revenues but Beats on EPS
Motley Fool
ISTA Pharmaceuticals
earnings
Buffett says may consider selling J&J stock
Buffett says may consider selling J&J stock
Reuters
JNJ
Warren Buffett
Auxilium Misses 4Q Estimates
Auxilium Misses 4Q Estimates
Yahoo/Zacks
Auxilium
earnings
China Biotech In Review: Newsummit To Stage $80 Million IPO On NYSE
China Biotech In Review: Newsummit To Stage $80 Million IPO On NYSE
Seeking Alpha
China
IPOs
Newsummit Biopharma
GENFIT's drug candidate GFT505 gets patent protection from major countries
GENFIT's drug candidate GFT505 gets patent protection from major countries
Pharmabiz
Genfit
GFT505
diabetes
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Genetic Engineering News
Forest Labs
Colobreathe
U.K. enjoys bargain-basement drug prices, report finds
U.K. enjoys bargain-basement drug prices, report finds
Fierce Pharma
drug prices
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »